Pepper patch takes on cancer nerve pain in new trial

NCT ID NCT04704453

Completed Symptom relief Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared a capsaicin patch (Qutenza) to a standard nerve pain medication (amitriptyline) in 13 head and neck cancer survivors with long-term nerve pain. The goal was to see if the patch could reduce pain and improve quality of life. Participants received either the patch every 3 months or daily pills, and were followed for 9 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK CANCER

Contacts and locations

Locations

Hôpital Saint-Joseph

Marseille, 13285, France
INSTITUT DE CANCEROLOGIE DE L'OUEST (ICO) Site Angers

Angers, France
Institut Sainte-Catherine

Avignon, France
Institut Universitaire du Cancer Toulouse - Oncopole

Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.